My Video Playlist »
Empty Playlist
|
|
|
Half of women in England diagnosed with cancer successfully beat the disease, according to a new study. The research publishe...
Half of women in England diagnosed with cancer successfully beat the disease, according to a new study. The research published in a special issue of the European Journal of Cancer...
1
|
Half of women in England diagnosed with cancer successfully beat the disease, according to a new study. The research publishe... |
|
|
|
|
|
|
beneficial for patients with HER2-positive metastatic breast cancer. Pertuzumab, which inhibitis a key mechanism of tumour gr...
beneficial for patients with HER2-positive metastatic breast cancer. Pertuzumab, which inhibitis a key mechanism of tumour growth, was found to benefit half of the patients whose...
0
|
beneficial for patients with HER2-positive metastatic breast cancer. Pertuzumab, which inhibitis a key mechanism of tumour gr... |
|
|
|
|
|
|
Dr. Edith Perez led trial of Herceptin advances breast cancer tratment for HER2+ breast cancer
Dr. Edith Perez led trial of Herceptin advances breast cancer tratment for HER2+ breast cancer
0
|
Dr. Edith Perez led trial of Herceptin advances breast cancer tratment for HER2+ breast cancer |
|
|
|
|
|
|
to liver failure. From Sydney - HDL, or the "good" type of cholesterol, is very important in preventing heart attack death in...
to liver failure. From Sydney - HDL, or the "good" type of cholesterol, is very important in preventing heart attack death in those with coronary artery disease. In a study of...
0
|
to liver failure. From Sydney - HDL, or the "good" type of cholesterol, is very important in preventing heart attack death in... |
|
|
|
|
|
|
"Living Proof is the true story of a UCLA oncologist who helped develop the breast cancer drug Herceptin. His inspring journe...
"Living Proof is the true story of a UCLA oncologist who helped develop the breast cancer drug Herceptin. His inspring journey shows the sacrafices he made and obstacles he faced...
0
|
"Living Proof is the true story of a UCLA oncologist who helped develop the breast cancer drug Herceptin. His inspring journe... |
|
|
|
|
|
|
"Living Proof is the true story of a UCLA oncologist who helped develop the breast cancer drug Herceptin. His inspring journe...
"Living Proof is the true story of a UCLA oncologist who helped develop the breast cancer drug Herceptin. His inspring journey shows the sacrafices he made and obstacles he faced...
0
|
"Living Proof is the true story of a UCLA oncologist who helped develop the breast cancer drug Herceptin. His inspring journe... |
|
|
|
|
|
|
CancerTv.com presents helpful news and information on cancer related topics. In this edition; Herceptin's effect on reducing ...
CancerTv.com presents helpful news and information on cancer related topics. In this edition; Herceptin's effect on reducing early breast cancer, how breast feeding lower's a...
0
|
CancerTv.com presents helpful news and information on cancer related topics. In this edition; Herceptin's effect on reducing ... |
|
|
|
|
|
|
"Living Proof is the true story of a UCLA oncologist who helped develop the breast cancer drug Herceptin. His inspring journe...
"Living Proof is the true story of a UCLA oncologist who helped develop the breast cancer drug Herceptin. His inspring journey shows the sacrafices he made and obstacles he faced...
0
|
"Living Proof is the true story of a UCLA oncologist who helped develop the breast cancer drug Herceptin. His inspring journe... |
|
|
|
|
|
|
Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck...
Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck Institute of Biochemistry in Germany, whose...
0
|
Johnson & Johnson today announced that Axel Ullrich, Ph.D., director of the Department of Molecular Biology at the Max Planck... |
|
|
|
|
|
|
Dr. Dennis Slamon, JCCC Director of Clinical/Translational Research, identifies different genes and pathways to design therap...
Dr. Dennis Slamon, JCCC Director of Clinical/Translational Research, identifies different genes and pathways to design therapies specifically to what drives cancer. The result is...
0
|
Dr. Dennis Slamon, JCCC Director of Clinical/Translational Research, identifies different genes and pathways to design therap... |
|
|
|
|
|
